Netscientific PLC (LON:NSCI)‘s stock had its “buy” rating reissued by research analysts at Stifel Nicolaus in a research report issued on Tuesday. They currently have a GBX 95 ($1.25) price target on the stock. Stifel Nicolaus’ price target suggests a potential upside of 46.38% from the stock’s previous close.

Shares of Netscientific PLC (LON:NSCI) opened at GBX 64.90 ($0.85) on Tuesday. Netscientific PLC has a 12 month low of GBX 36 ($0.47) and a 12 month high of GBX 73.80 ($0.97).

Netscientific PLC (LON:NSCI) last issued its quarterly earnings data on Thursday, September 28th. The company reported GBX (8.80) (($0.12)) earnings per share for the quarter. Netscientific PLC had a negative return on equity of 51.79% and a negative net margin of 3,144.51%. The company had revenue of GBX 16 million for the quarter.

ILLEGAL ACTIVITY WARNING: This report was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.watchlistnews.com/netscientific-plc-nsci-stock-rating-reaffirmed-by-stifel-nicolaus/1721031.html.

Netscientific PLC Company Profile

NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics.

Receive News & Ratings for Netscientific PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netscientific PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.